• First Prize – Pravin Shah Award for the presentation on Home Hemodialysis and Aluminium Toxicity in Patients Receiving Hemodialysis.
• Third Prize for Oral Presentation on Pneumocystis Jiroveci in Immunocompromised Kidney Patients at ISOT Nashik Mid-Term.
• Second Prize for Mini Oral Presentation on Comparison Between Low-Dose and High-Dose Rituximab in ABO-Incompatible and DSA-Positive Post-Kidney Transplant Patients at ISOT Ahmedabad.
• Torrent Young Scholar Award (TYSA) – Reached the top six candidates.

Thesis

• Red Cell Distribution Width in Sepsis and Septic Shock Patients – M.D. General Medicine.
• Clinical Response and Pattern of B-Cell Suppression with Variable Doses of Rituximab in Kidney Transplant Recipients – DrNB Nephrology.

Presentations

• Takayasu Arteritis with Multiorgan Involvement – Vidarbha Association of Physicians (VAPICON).
• Home Hemodialysis—Can It Be a Hazard? Aluminium Toxicity in Patients Receiving Hemodialysis – IZN West Zone, Aurangabad.
• A Case Report of Cryptococcus Pneumonitis in Post-Kidney Transplant – Indian Society of Transplantation (ISOT).
• A Rare Case Report of Bortezomib-Induced Stevens–Johnson Syndrome – Indian Society of Nephrology (ISN), Pune.
• Challenges in Detection and Treatment of Atypical Mycobacterial Infection in Kidney Transplant Recipient – ISN West Zone, Rajkot.
• Case Series of Non-Mycobacterium Tuberculosis in Post-Kidney Transplant Patients – ISOT Nashik.
• Pneumocystis Jiroveci in Immunocompromised Kidney Patients.
• Clinical Response and Pattern of B-Cell Suppression with Variable Doses of Rituximab in Kidney Transplants – The Transplantation Society (TTS).
• Comparison Between Low-Dose and High-Dose Rituximab in ABO-Incompatible and DSA-Positive Post-Kidney Transplant Patients – ISOT Ahmedabad.
• Long-Term Results of Endovascular Stenting for Renal Artery Stenosis in Kidney Transplant Recipients – World Congress of Nephrology (WCN), Delhi.

Publications

• A Rare Case Report of Bortezomib-Induced Stevens–Johnson Syndrome. Indian Journal of Nephrology, 2022; 32 (Suppl 1).
• Clinical Response and Pattern of B-Cell Suppression with Variable Dose of Rituximab in Kidney Transplants. Transplantation, 108(9S), September 2024.
• Long-Term Results of Endovascular Stenting for Renal Artery Stenosis in Kidney Transplant Recipients. Kidney International Reports, Volume 10, Issue 2, S492.
• An Observational Study of C/D Ratio to Predict CYP3A5 Genotype Polymorphism and Tacrolimus Metabolism in Indian Renal Transplant Patients. Kidney International Reports, Volume 10, Issue 2, S523.
• Use of Empirical Deflazacort to Preserve Kidney Function and Delay Onset of Renal Replacement Therapy in Patients with CKD of Unknown Etiology. Kidney International Reports, Volume 10, Issue 2, S523.
• De Novo Use of Everolimus in Renal Transplant Patients: Post-Operative Complications; Pneumonia Masquerading Everolimus Toxicity? Transplantation, 108(9S), September 2024.
• A Targeted Approach of Antibiotics as Future Perspective. APCN 2024, Abstract 1186.

• Nephrology
• Kidney Transplantation
• Hemodialysis
• Continuous Renal Replacement Therapy (CRRT)
• Sustained Low-Efficiency Dialysis (SLED)
• Renal Biopsy
• Critical Care Nephrology
• Plasma Exchange
• Transplant Immunology